Ziagen
Formulated to target HIV infection to support immune system health in combination with other treatments.
- Category
- HIV Management
- Active ingredient
- Abacavir
- Supply
- Rx
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 300mg
Ziagen details
- Condition
- HIV Infection
- Therapeutic class
- Nucleoside Reverse Transcriptase Inhibitor (NRTI)
- Pharmacological class
- NRTI
- Contraindications
- hypersensitivity to abacavir; hepatic impairment
- Minor side effects
- nausea; headache; fatigue
- Moderate side effects
- diarrhoea; fever; rash
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- ViiV Healthcare
- Onset Time
- n/a
- Duration
- n/a
- Storage instructions
- Store at room temperature.
- Drug interactions
- Alcohol; Methadone
- Age restrictions
- Use requires medical supervision.
- Pregnancy and breastfeeding
- Discuss risks with your healthcare provider.
Precautions and warnings
monitor for hypersensitivity reactions; genetic testing for HLA-B*5701 recommended
Serious side effects
hypersensitivity reaction, requires immediate medical attention; lactic acidosis, requires immediate medical attention
Patient summary
Formulated to target HIV infection to support immune system health in combination with other treatments.
Mechanism of action
Abacavir is a nucleoside analogue reverse transcriptase inhibitor that prevents viral replication within host cells.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Ziagen
Ziagen contains abacavir, one of the primary medications utilised for the management of HIV Infection. Manufactured by ViiV Healthcare, this product is supplied as a 300mg tablet. It acts as a nucleoside reverse transcriptase inhibitor, providing a standardised option for patients maintaining their specific treatment plan with a consistent dosage form.
Ziagen availability in Asia
Ziagen is registered across 14 markets, including South Korea, Japan and the UAE, with availability also in Singapore, Hong Kong and Thailand. While the original brand is well recognised, generic abacavir, often manufactured in India, remains a common and more affordable alternative for expats and residents far from a well stocked pharmacy. As with any antiretroviral therapy, this medication is best used under the ongoing guidance and care of a qualified doctor to ensure proper management of HIV Infection.